Reviva Pharmaceuticals exotic insider transaction detected

RVPH Stock  USD 1.40  0.90  39.13%   
Under 55% of Reviva Pharmaceuticals' traders are presently thinking to get in. The analysis of the overall investor sentiment regarding Reviva Pharmaceuticals Holdings suggests that some traders are interested. Reviva Pharmaceuticals' investing sentiment shows overall attitude of investors towards Reviva Pharmaceuticals Holdings.
  
Filed transaction by Reviva Pharmaceuticals Ho executive. Unconventional Insider trading

Read at macroaxis.com
Reviva insider trading alert for general transaction of ordinary shares by Glazer Capital Llc, the corporate stakeholder, on 21st of May 2023. This event was filed by Reviva Pharmaceuticals Ho with SEC on 2020-09-11. Initial filing of beneficial ownership - SEC Form 3

Reviva Pharmaceuticals Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Reviva Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Reviva Pharmaceuticals Fundamental Analysis

We analyze Reviva Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Reviva Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Reviva Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Book Value Per Share

Book Value Per Share Comparative Analysis

Reviva Pharmaceuticals is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.

Reviva Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Reviva Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Reviva Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Reviva Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Reviva Pharmaceuticals Related Equities

ZVSAZyVersa Therapeutics   10.00   
0%
100.0%
CUECue Biopharma   3.92   
0%
39.0%
INABIn8bio   3.57   
0%
35.0%
CABACabaletta Bio   1.48   
0%
14.0%
PLXProtalix Biotherapeutics   0.57   
5.0%
0%
UNCYUnicycive Therapeutics   1.41   
14.0%
0%
FBIOFortress Biotech   2.75   
27.0%
0%
ACADACADIA Pharmaceuticals   2.87   
28.0%
0%
LTRNLantern Pharma   3.65   
36.0%
0%
SLSSellas Life   4.35   
43.0%
0%
EYPTEyepoint Pharmaceuticals   7.23   
72.0%
0%
ATHAAthira Pharma   8.47   
84.0%
0%

Complementary Tools for Reviva Stock analysis

When running Reviva Pharmaceuticals' price analysis, check to measure Reviva Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reviva Pharmaceuticals is operating at the current time. Most of Reviva Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Reviva Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reviva Pharmaceuticals' price. Additionally, you may evaluate how the addition of Reviva Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum